cerebrovascular disease (CVD)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients with cerebrovascular disease (CVD) presenting with hemiplegia 2) Age: 20 years <= at entry 3) Duration after onset ranges from 14 to 90 days 4) Able to walk 10 m (even with walking aids such as cane or walker) 5) Able to keep admission in Kakeyu-Misayama Rehabilitation Center, Kakeyu Hospital during the study 6) Berg balance Scale: 26<= 7) Written informed consent for the study
Exclusion criteria
Exclusion criteria: 1) Possible causes for gait disturbance other than CVD 2) Not fulfil the body-size criteria for curara(R) model 4 3) Researchers judge the participants inappropriate for the study (for example, severe dementia or psychiatric symptoms, severe spasticity or joint contracture of paralyzed leg, etc.)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 10m walking speed (comparison between day 0 and day 14) [day 0, day 7, day 14] [] indicates day of evaluation | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) 6-min walking distance (comparison between day 0 and day 14) 2) RehaGait(R) measures 3) Berg Balance Scale (BBS) [day 0, day 14] 4) Timed up and go test 5) Outcome measures reported by participants [day 14] 6) Safety sheet (interview to participants) [at least 1 day during 3 days just prior to day 0 and day 0-day 14] Items not specified above by [] are evaluated three times, day 0, day 7, and day 14. | — |
Countries
Japan
Contacts
Shinshu University School of Medicine Department of Brain Disease Research